Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Miyajima

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Journal of Gastroenterology|October 31, 2017
Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis CToshihiro Kawaguchi, Tatsuya Ide, Hironori Koga, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 26, 2017
Risk of malignancies in autoimmune hepatitis type 1 patients with a long-term follow-up in JapanTeruko Arinaga-Hino, Tatsuya Ide, Ichiro Miyajima, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 8, 2025
Isepamicin alone as antimicrobial prophylaxis for transrectal prostate needle biopsy: "Do we still need levofloxacin? "Hiroki Yamada, Kojiro Tashiro, Yusuke Takahashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 24, 2002
Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis CRyukichi Kumashiro, Tatsuya Ide, Masaru Sasaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 29, 2023
Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancerTomoyuki Nakane, Shuhei Fukunaga, Dan Nakano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 5, 2023
Impact of non-obese metabolic dysfunction-associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter studyShuhei Fukunaga, Michita Mukasa, Tomoyuki Nakane, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 17, 2023
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter studyTomoya Sano, Keisuke Amano, Tatsuya Ide, et al.
Plos One|September 30, 2016
Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1Tatsuya Ide, Yuichiro Eguchi, Masaru Harada, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Journal of Gastroenterology|October 31, 2017
Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis CToshihiro Kawaguchi, Tatsuya Ide, Hironori Koga, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 26, 2017
Risk of malignancies in autoimmune hepatitis type 1 patients with a long-term follow-up in JapanTeruko Arinaga-Hino, Tatsuya Ide, Ichiro Miyajima, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 8, 2025
Isepamicin alone as antimicrobial prophylaxis for transrectal prostate needle biopsy: "Do we still need levofloxacin? "Hiroki Yamada, Kojiro Tashiro, Yusuke Takahashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 24, 2002
Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis CRyukichi Kumashiro, Tatsuya Ide, Masaru Sasaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 29, 2023
Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancerTomoyuki Nakane, Shuhei Fukunaga, Dan Nakano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 5, 2023
Impact of non-obese metabolic dysfunction-associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter studyShuhei Fukunaga, Michita Mukasa, Tomoyuki Nakane, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 17, 2023
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter studyTomoya Sano, Keisuke Amano, Tatsuya Ide, et al.
Plos One|September 30, 2016
Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1Tatsuya Ide, Yuichiro Eguchi, Masaru Harada, et al.
Pageof 2